Floatz logo

Therapeutic Asset Ratings

141 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
FLUOROURACILUM
Metastatic Cancer
I-Mab Biopharma US LimitedP3BB (70)
(+)-VINCRISTINE
Metastatic Cancer
Incyte CorporationP2/3BB (70)
Calcium folinate pentahydrate
Metastatic Cancer
I-Mab Biopharma US LimitedP3BB (69)
Irinotecan
Metastatic Cancer
Incyte CorporationP3BB (69)
FILGRASTIM
Metastatic Cancer
Mayo ClinicP3BB (68)
Cyclophosphamide
Metastatic Cancer
InSilico Medicine Hong Kong LimitedP2/3BB (67)
Epirubicin
Metastatic Cancer
InSilico Medicine Hong Kong LimitedP2/3BB (67)
Pembrolizumab
Metastatic Cancer
InSilico Medicine Hong Kong LimitedP2/3BB (67)
DEXAMETHASONE
Metastatic Cancer
GenmabP3BB (66)
Eloxatin
Metastatic Cancer
I-Mab Biopharma US LimitedP3BB (65)
Inno-206
Metastatic Cancer
City of Hope Medical CenterP3BB (65)
Zoledronate
Metastatic Cancer
Kelly Fitzgerald, MDP3BB (65)
FLUTICASONE
Metastatic Cancer
Mayo ClinicP2BB (65)
CIS-DIAMMINEDICHLOROPLATINUM II
Metastatic Cancer
InSilico Medicine Hong Kong LimitedP3BB (64)
Docetaxel
Metastatic Cancer
InSilico Medicine Hong Kong LimitedP3BB (64)
Floxuridine
Metastatic Cancer
Memorial Sloan Kettering Cancer CenterP3BB (64)
LENVATINIB
Metastatic Cancer
Salubris Biotherapeutics IncP3BB (64)
Nivolumab
Metastatic Cancer
Fred Hutchinson Cancer CenterP3BB (64)
Tislelizumab
Metastatic Cancer
BeOne MedicinesP3BB (64)
Sargramostim
Metastatic Cancer
Mayo ClinicP2BB (64)
Capecitabine
Metastatic Cancer
I-Mab Biopharma US LimitedP3B (63)
Cetuximab
Metastatic Cancer
Revolution Medicines, Inc.P3B (63)
Evomela
Metastatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP3B (63)
FULVESTRANT
Metastatic Cancer
Taiho Oncology, Inc.P3B (63)
Letrozole
Metastatic Cancer
Fudan UniversityP3B (63)
Showing 1 to 25 of 141 assets
PreviousPage 1 of 6Next